1. Rubio-Rivas, M, Royo, C, Simeon, CP, et al. Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 2014; 44(2): 208–219.
Google Scholar | Crossref | Medline2. D’Angelo, WA, Fries, JF, Masi, AT, et al. Pathologic observations in systemic sclerosis (scleroderma). Am J Med 1969; 46(3): 428–440.
Google Scholar | Crossref | Medline3. Weaver, AL, Divertie, MB, Titus, JL. Pulmonary scleroderma. Dis Chest 1968; 54: 490–498.
Google Scholar | Crossref | Medline4. Bjerke, RD, Tashkin, DP, Clements, PJ, et al. Small airways in progressive systemic sclerosis (PSS). Am J Med 1979; 66: 201–209.
Google Scholar | Crossref | Medline5. Guttadauria, M, Ellman, H, Emmanuel, G, et al. Pulmonary function in scleroderma. Arthritis Rheum 1977; 20: 1071–1079.
Google Scholar | Crossref | Medline6. Steen, VD, Owens, GR, Fino, GJ, et al. Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum 1985; 28(7): 759–767.
Google Scholar | Crossref | Medline7. Wells, AU. High-resolution computed tomography and scleroderma lung disease. Rheumatology (Oxford) 2008; 47(Suppl. 5): v59–v61.
Google Scholar | Crossref | Medline8. Goldin, JG, Lynch, DA, Strollo, DC, et al. High-resolution ct scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest 2008; 134(2): 358–367.
Google Scholar | Crossref | Medline9. Antoniou, KM, Margaritopoulos, GA, Goh, NS, et al. Combined pulmonary fibrosis and emphysema in scleroderma-related lung disease has a major confounding effect on lung physiology and screening for pulmonary hypertension. Arthritis Rheumatol 2016; 68(4): 1004–1012.
Google Scholar | Crossref | Medline10. Champtiaux, N, Cottin, V, Chassagnon, G, et al. Combined pulmonary fibrosis and emphysema in systemic sclerosis: a syndrome associated with heavy morbidity and mortality. Semin Arthritis Rheum 2019; 49(1): 98–104.
Google Scholar | Crossref | Medline11. McDonough, JE, Yuan, R, Suzuki, M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011; 365: 1567–1575.
Google Scholar | Crossref | Medline12. Hogg, JC, McDonough, JE, Suzuki, M. Small airway obstruction in COPD: new insights based on micro-ct imaging and MRI imaging. Chest 2013; 143(5): 1436–1443.
Google Scholar | Crossref | Medline13. Tashkin, DP, Roth, MD, Clements, PJ, et al. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med 2016; 4(9): 708–719.
Google Scholar | Crossref | Medline14. Preliminary Criteria for the Classification of Systemic Sclerosis (Scleroderma) . Subcommittee for scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee. Arthritis Rheum 1980; 23(5): 581–590.
Google Scholar | Medline15. Medsger, TA Classification, prognosis. In: Clements, P, Furst, DE (eds) Systemic sclerosis. 2nd ed. New York: Lippincott Williams & Wilkins, 2004, pp. 129–50.
Google Scholar16. Mahler, DA, Weinberg, DH, Wells, CK, et al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85(6): 751–758.
Google Scholar | Crossref | Medline17. Park, CS, Muller, NL, Worthy, SA, et al. Airway obstruction in asthmatic and healthy individuals: inspiratory and expiratory thin-section ct findings. Radiology 1997; 203(2): 361–367.
Google Scholar | Crossref | Medline18. Hansell, DM, Bankier, AA, MacMahon, H, et al. Fleischner society: glossary of terms for thoracic imaging. Radiology 2008; 246: 697–722.
Google Scholar | Crossref | Medline19. Kligerman, SJ, Henry, T, Lin, CT, et al. Mosaic attenuation: etiology, methods of differentiation, and pitfalls. Radiographics 2015; 35(5): 1360–1380.
Google Scholar | Crossref | Medline20. Kim, HG, Tashkin, DP, Clements, PJ, et al. A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients. Clin Exp Rheumatol 2010; 28(5 Suppl. 62): S26–S35.
Google Scholar | Medline21. Khanna, D, Nagaraja, V, Tseng, CH, et al. Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials. Arthritis Res Ther 2015; 17: 372.
Google Scholar | Crossref | Medline22. Miller, MR, Hankinson, J, Brusasco, V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319–338.
Google Scholar | Crossref | Medline23. Pellegrino, R, Viegi, G, Brusasco, V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948–968.
Google Scholar | Crossref | Medline24. Wanger, J, Clausen, JL, Coates, A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26(3): 511–522.
Google Scholar | Crossref | Medline25. Hankinson, JL, Odencrantz, JR, Fedan, KB. Spirometric reference values from a sample of the general U.S. Population. Am J Respir Crit Care Med 1999; 159(1): 179–187.
Google Scholar | Crossref | Medline26. McFadden, ER, Linden, DA. A reduction in maximum mid-expiratory flow rate. A spirographic manifestation of small airway disease. Am J Med 1972; 52: 725–737.
Google Scholar | Crossref | Medline27. McNulty, W, Usmani, OS. Techniques of assessing small airways dysfunction. Eur Clin Respir J 2014; 1: 25898.
Google Scholar | Crossref28. Crapo, RO, Morris, AH, Clayton, PD, et al. Lung volumes in healthy nonsmoking adults. Bull Eur Physiopathol Respir 1982; 18(3): 419–425.
Google Scholar | Medline29. Society, AT. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis 1991; 144: 1202–1218.
Google Scholar | Crossref | Medline30. Stocks, J, Quanjer, PH. Reference values for residual volume, functional residual capacity and total lung capacity. ATS workshop on lung volume measurements. Official statement of the European respiratory society. Eur Respir J 1995; 8(3): 492–506.
Google Scholar31. Beretta, L, Santaniello, A, Lemos, A, et al. Validity of the saint George’s respiratory questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis. Rheumatology (Oxford) 2007; 46(2): 296–301.
Google Scholar | Crossref | Medline32. Mahler, DA, Ward, J, Fierro-Carrion, G, et al. Development of self-administered versions of modified baseline and transition dyspnea indexes in copd. COPD 2004; 1(2): 165–172.
Google Scholar | Crossref | Medline33. Bae, S, Allanore, Y, Furst, DE, et al. Associations between a scleroderma-specific gastrointestinal instrument and objective tests of upper gastrointestinal involvements in systemic sclerosis. Clin Exp Rheumatol 2013; 31(2 Suppl. 76): 57–63.
Google Scholar | Medline34. Shreiner, AB, Murray, C, Denton, C, et al. Gastrointestinal manifestations of systemic sclerosis. J Scleroderma Relat Disord 2016; 1: 247–256.
Google Scholar | SAGE Journals35. Kreuter, M, Raghu, G. Gastro-oesophageal reflux and idiopathic pulmonary fibrosis: the heart burn in patients with IPF can no longer be silent. Eur Respir J 2018; 51(6): 1800921.
Google Scholar | Crossref | Medline36. Bedard Methot, D, Leblanc, E, Lacasse, Y. Meta-analysis of gastroesophageal reflux disease and idiopathic pulmonary fibrosis. Chest 2019; 155(1): 33–43.
Google Scholar | Crossref | Medline37. Spain, DM, Thomas, AG. The pulmonary manifestations of scleroderma; an anatomic-physiological correlation. Ann Intern Med 1950; 32(1): 152–161.
Google Scholar | Crossref | Medline38. Ritchie, B. Pulmonary function in scleroderma. Thorax 1964; 19: 28–36.
Google Scholar | Crossref | Medline39. Hughes, DT, Lee, FI. Lung function in patients with systemic sclerosis. Thorax 1963; 18: 16–20.
Google Scholar | Crossref | Medline40. Yamakawa, H, Takemura, T, Iwasawa, T, et al. Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy? BMC Pulm Med 2018; 18: 25.
Google Scholar | Crossref | Medline41. Burrows, B, Bloom, JW, Traver, GA, et al. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987; 317: 1309–1314.
Google Scholar | Crossref | Medline42. Deepak, D, Prasad, A, Atwal, SS, et al. Recognition of small airways obstruction in asthma and copd—the road less travelled. J Clin Diagn Res 2017; 11(3): TE01–TE05.
Google Scholar43. Cottin, V, Nunes, H, Mouthon, L, et al. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum 2011; 63(1): 295–304.
Google Scholar | Crossref | Medline44. Jankowich, MD, Rounds, S. Combined pulmonary fibrosis and emphysema alters physiology but has similar mortality to pulmonary fibrosis without emphysema. Lung 2010; 188(5): 365–373.
Google Scholar | Crossref | Medline45. Saldana, DC, Coxson, HO, Ryerson, CJ. Reply: quantitative CT in SSC-ILD: are we ready to go beyond standard assessment? Annalsats 2020; 18: 1184LE.
Google Scholar46. Saldana, DC, Hague, CJ, Murphy, D, et al. Association of computed tomography densitometry with disease severity, functional decline, and survival in systemic sclerosis-associated interstitial lung disease. Ann Am Thorac Soc 2020; 17(7): 813–820.
Google Scholar | Crossref | Medline47. Quanjer, PH, Stanojevic, S, Cole, TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40: 1324–43.
Google Scholar | Crossref